Botanical species · safety record

Andrographis paniculata

The EFSA Compendium of Botanicals holds 11 constituent measurements and 5 adverse-effect records for Andrographis paniculata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Andrographis paniculata (Burm.f.) Nees

11Constituent measurements
5Safety records
5Cited sources
269Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 269 licensed products naming Andrographis paniculata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • solid

Source material stated

  • Aerial parts
  • Aerial parts extract
  • Andrographis paniculata - Leaf
  • Dried aerial part(s)
  • Dried aerial parts (not less than 30% leaves)
  • Flower
  • Fresh above ground parts
  • Herb

What the records describe

Constituents measured

  • Andrographolide5
  • Deoxyandrographolide3
  • Neoandrographolide3

Plant parts

  • Leaves12
  • Roots and other underground parts3
  • Live plants1

Preparations

  • Solvent extraction15

Effect types

  • Digestive4
  • Reproductive1

Target tissues

  • Digestive4
  • Testes1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AndrographolideRoots and other underground partsSolvent extraction26.53 Milligram/gramHPLC-DADResolve DOI
AndrographolideLeavesSolvent extractionGC-MS (Q)Resolve DOI
AndrographolideLeavesSolvent extraction≥ 37.29 Milligram/gramHPLC-DADResolve DOI
AndrographolideLeavesSolvent extraction≤ 38.83 Milligram/gramHPLC-DADResolve DOI
AndrographolideLive plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
DeoxyandrographolideLeavesSolvent extraction≥ 26.49 Milligram/gramHPLC-DADResolve DOI
DeoxyandrographolideLeavesSolvent extraction≤ 28.42 Milligram/gramHPLC-DADResolve DOI
DeoxyandrographolideRoots and other underground partsSolvent extraction17.47 Milligram/gramHPLC-DADResolve DOI
NeoandrographolideRoots and other underground partsSolvent extraction6.7 Milligram/gramHPLC-DADResolve DOI
NeoandrographolideLeavesSolvent extraction≤ 11.45 Milligram/gramHPLC-DADResolve DOI
NeoandrographolideLeavesSolvent extraction≥ 10.37 Milligram/gramHPLC-DADResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveTestesLeavesRat (as animal)Reproduction toxicityResolve DOI
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kurzawa, Marzanna., Filipiak-Szok, Anna., Klodzinska, Ewa., Szlyk, Edward. Determination of phytochemicals, antioxidant activity and total phenolic content in Andrographis paniculata using chromatographic methods . Journal of chromatography b-analytical technologies in the biomedical and life sciences, 2015, vol. 995, p. 101-106. DOI
  2. Subramanian, Rammohan., Asmawi, M. Zaini., Sadikun, Amirin. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide . Acta biochimica polonica, 2008, vol. 55, no. 2, p. 391-398.
  3. Edwin, Edward-Sam., Vasantha-Srinivasan, Prabhakaran., Senthil-Nathan, Sengottayan., Thanigaivel, Annamalai., Ponsankar, Athirstam., Pradeepa, Venkatraman., Selin-Rani, Selvaraj., Kalaivani, Kandaswamy., Hunter, Wayne B., Abdel-Megeed, Ahmed., Duraipandiyan, Veeramuthu., Al-Dhabi, Naif Abdullah. Anti-dengue efficacy of bioactive andrographolide from Andrographis paniculata (Lamiales: Acanthaceae) against the primary dengue vector Aedes aegypti (Diptera: Culicidae) . Acta tropica, 2016, vol. 163, p. 167-178. DOI
  4. Akbarsha, MA., Murugaian, P. Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: Effect on the testis and the cauda epididymidal spermatozoa . Phytotherapy research, 2000, vol. 14, no. 6, p. 432-435. DOI
  5. Sheeja, K., Kuttan, G. Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide . Immunopharmacology and immunotoxicology, 2007, vol. 29, no. 1, p. 81-93. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue